![Richard Simon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Richard Simon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sensorium Therapeutics, Inc.
![]() Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sensorium Therapeutics, Inc. is a biotechnology company based in Massachusetts. Sensorium Therapeutics leverages cutting-edge chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health. The American company's groundbreaking biodynamic discovery platform™ rapidly identifies, reproduces, adapts, and enhances targeted molecules to deliver transformational benefits to patients around the world. The company completed a $30m series A financing in late 2023 led by Santé Ventures, with participation from Route 66 Ventures, CU Healthcare Innovation Fund, and others. The company was founded by Jerrold F. Rosenbaum, Jacob Hooker, Richard Simon, Alex Simon, and Stephen Haggarty. Richard Simon has been the CEO since incorporation. | Directeur/Bestuurslid | 01-06-2021 | - |
Oprichter | - | - | |
Algemeen Directeur | 01-06-2021 | 04-12-2023 |
Loopbaan van Richard Simon
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Sensorium Therapeutics, Inc.
![]() Sensorium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sensorium Therapeutics, Inc. is a biotechnology company based in Massachusetts. Sensorium Therapeutics leverages cutting-edge chemistry, neuroscience, and machine learning to develop nature-inspired psychoactive medicines for mental health. The American company's groundbreaking biodynamic discovery platform™ rapidly identifies, reproduces, adapts, and enhances targeted molecules to deliver transformational benefits to patients around the world. The company completed a $30m series A financing in late 2023 led by Santé Ventures, with participation from Route 66 Ventures, CU Healthcare Innovation Fund, and others. The company was founded by Jerrold F. Rosenbaum, Jacob Hooker, Richard Simon, Alex Simon, and Stephen Haggarty. Richard Simon has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Richard Simon
- Ervaring